Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical expulsive therapy using diuretics and alpha-blockers after shock wave lithotripsy of kidney stones
2024-510792-38-00Phase 3Withdrawn
- Sponsor
- Central Denmark Region
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin and furosemide in nephrolithiasis and ureterolithiasis, sponsored by Central Denmark Region. Primary endpoint: Stone clearance at 4 weeks after last ESWL. Planned start Apr 2024; status: withdrawn.
02
Drugs
tamsulosinfurosemide
03
Conditions
nephrolithiasisureterolithiasis
Beyond the preview
Go deeper on 2024-510792-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510792-38-00.